Insider · CIK 0001744507
Adam Dubow
officer
Files at DAWN (Day One Biopharmaceuticals, Inc.). First filing Nov 17, 2023, latest Feb 18, 2026.
In brief
Adam Dubow files SEC Form 4 as officer at DAWN (Day One Biopharmaceuticals, Inc.). Since Nov 17, 2023, Adam Dubow has reported 0 open-market buys worth $0 and 7 open-market sells worth $330k, the latest filed on Feb 18, 2026.
A track record needs three past buys with six months of prices behind them; Adam Dubow has 0, so none is measured yet.
The newest scored trade: sold $74k of DAWN on Feb 17, 2026, filed Feb 18, 2026, scored 23 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $113k.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $330k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Day One Biopharmaceuticals, Inc. | $74k 6,395 shares | -8% | - | |
| 21Weak | Day One Biopharmaceuticals, Inc. | $39k 4,319 shares | -6% | - | |
| 20Weak | Day One Biopharmaceuticals, Inc. | $30k 4,365 shares | -7% | - | |
| 20Weak | Day One Biopharmaceuticals, Inc. | $28k 4,552 shares | -9% | - | |
| 27Weak | Day One Biopharmaceuticals, Inc. | $56k 4,646 shares | -10% | - | |
| 21Weak | Day One Biopharmaceuticals, Inc. | $42k 3,165 shares | -9% | - | |
| 32Weak | Day One Biopharmaceuticals, Inc. | $62k 5,313 shares | -32% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 17, 2026 | DAWN DAY ONE BIOPHARMACEUTICALS, INC. | 6,395 0.01% of outstanding | $74k | Feb 17, 2026 | none |
| Nov 17, 2025 | DAWN DAY ONE BIOPHARMACEUTICALS, INC. | 4,319 0.00% of outstanding | $39k | Nov 17, 2025 | $30k |
| May 16, 2025 | DAWN DAY ONE BIOPHARMACEUTICALS, INC. | 4,552 0.00% of outstanding | $28k | May 16, 2025 | $56k |
| Feb 18, 2025 | DAWN DAY ONE BIOPHARMACEUTICALS, INC. | 4,646 0.00% of outstanding | $56k | Feb 18, 2025 | none |
| Nov 16, 2023 | DAWN DAY ONE BIOPHARMACEUTICALS, INC. | 5,313 0.01% of outstanding | $62k | Nov 16, 2023 | $9,149 |
Transactions
The newest 50 of 81 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Common Stock | -72,694 | - | - | 0 | Apr 23, 2026 |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy Common Stock)derivative | -309,000 | - | - | 0 | Apr 23, 2026 |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy Common Stock)derivative | -90,000 | - | - | 0 | Apr 23, 2026 |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy Common Stock)derivative | -90,000 | - | - | 0 | Apr 23, 2026 |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy Common Stock)derivative | -90,000 | - | - | 0 | Apr 23, 2026 |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy Common Stock)derivative | -105,000 | - | - | 0 | Apr 23, 2026 |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Restricted Stock Unit (RSU)derivative | -8,889 | - | - | 0 | Apr 23, 2026 |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Restricted Stock Unit (RSU)derivative | -5,250 | - | - | 0 | Apr 23, 2026 |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Restricted Stock Unit (RSU)derivative | -25,816 | - | - | 0 | Apr 23, 2026 |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Restricted Stock Unit (RSU)derivative | -40,565 | - | - | 0 | Apr 23, 2026 |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Restricted Stock Unit (RSU)derivative | -65,625 | - | - | 0 | Apr 23, 2026 |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +2,963 | - | - | 65,589 | Feb 18, 2026 |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +1,750 | - | - | 67,339 | Feb 18, 2026 |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +3,688 | - | - | 71,027 | Feb 18, 2026 |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +3,687 | - | - | 74,714 | Feb 18, 2026 |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +4,375 | - | - | 79,089 | Feb 18, 2026 |
| Feb 17, 2026 | DAWN Day One Biopharmaceuticals, Inc. | SOpen-market sale Common Stock | -6,395 | $11.60 | $74k | 72,694 | Feb 18, 2026 |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -2,963 | $0.00 | $0 | 8,889 | Feb 18, 2026 |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -1,750 | $0.00 | $0 | 5,250 | Feb 18, 2026 |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -3,688 | $0.00 | $0 | 25,816 | Feb 18, 2026 |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -3,687 | $0.00 | $0 | 40,565 | Feb 18, 2026 |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -4,375 | $0.00 | $0 | 65,625 | Feb 18, 2026 |
| Jan 30, 2026 | DAWN Day One Biopharmaceuticals, Inc. | AGrant or award Stock Option (right to buy Common Stock)derivative | +105,000 | $0.00 | $0 | 105,000 | Jan 30, 2026 |
| Jan 30, 2026 | DAWN Day One Biopharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +70,000 | $0.00 | $0 | 70,000 | Jan 30, 2026 |
| Nov 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +2,963 | - | - | 57,821 | Nov 18, 2025 |
| Nov 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +1,750 | - | - | 59,571 | Nov 18, 2025 |
| Nov 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +3,687 | - | - | 63,258 | Nov 18, 2025 |
| Nov 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +3,687 | - | - | 66,945 | Nov 18, 2025 |
| Nov 17, 2025 | DAWN Day One Biopharmaceuticals, Inc. | SOpen-market sale Common Stock | -4,319 | $8.91 | $39k | 62,626 | Nov 18, 2025 |
| Nov 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -2,963 | $0.00 | $0 | 11,852 | Nov 18, 2025 |
| Nov 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -1,750 | $0.00 | $0 | 7,000 | Nov 18, 2025 |
| Nov 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -3,687 | $0.00 | $0 | 29,504 | Nov 18, 2025 |
| Nov 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -3,687 | $0.00 | $0 | 44,252 | Nov 18, 2025 |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc. | AGrant or award Stock Option (right to buy Common Stock)derivative | +309,000 | $0.00 | $0 | 309,000 | Nov 7, 2025 |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy Common Stock)derivative | -90,000 | $0.00 | $0 | 0 | Nov 7, 2025 |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc. | AGrant or award Stock Option (right to buy Common Stock)derivative | +90,000 | $0.00 | $0 | 90,000 | Nov 7, 2025 |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy Common Stock)derivative | -90,000 | $0.00 | $0 | 0 | Nov 7, 2025 |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc. | AGrant or award Stock Option (right to buy Common Stock)derivative | +90,000 | $0.00 | $0 | 90,000 | Nov 7, 2025 |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy Common Stock)derivative | -90,000 | $0.00 | $0 | 0 | Nov 7, 2025 |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc. | AGrant or award Stock Option (right to buy Common Stock)derivative | +90,000 | $0.00 | $0 | 90,000 | Nov 7, 2025 |
| Aug 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +2,963 | - | - | 50,099 | Aug 19, 2025 |
| Aug 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +1,750 | - | - | 51,849 | Aug 19, 2025 |
| Aug 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +3,687 | - | - | 55,536 | Aug 19, 2025 |
| Aug 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +3,687 | - | - | 59,223 | Aug 19, 2025 |
| Aug 18, 2025 | DAWN Day One Biopharmaceuticals, Inc. | SOpen-market sale Common Stock | -4,365 | $6.77 | $30k | 54,858 | Aug 19, 2025 |
| Aug 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -2,963 | $0.00 | $0 | 14,815 | Aug 19, 2025 |
| Aug 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -1,750 | $0.00 | $0 | 8,750 | Aug 19, 2025 |
| Aug 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -3,687 | $0.00 | $0 | 33,191 | Aug 19, 2025 |
| Aug 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -3,687 | $0.00 | $0 | 47,939 | Aug 19, 2025 |
| May 15, 2025 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +2,962 | - | - | 42,564 | May 19, 2025 |
50 of 81 rows shown.
Questions about Adam Dubow
Answered from the filings on this page, as of the latest one.
Is Adam Dubow buying or selling?
In the last 12 months Adam Dubow reported 0 open-market buys worth $0 and 2 open-market sells worth $113k on SEC Form 4; the latest was sold $74k of DAWN on Feb 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Adam Dubow's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adam Dubow has 0.
Where does Adam Dubow file Form 4?
Adam Dubow has filed Form 4 at DAWN (Day One Biopharmaceuticals, Inc.) as General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.